title: Pharmacologic therapies for infantile hemangioma:  is there a rational basis?
authors.affiliation: Division of Plastic Surgery, University of British Columbia, and, British Columbia Children's Hospital, Vancouver, British Columbia, Canada, jugpal.arneja@ubc.ca.
authors.forename: Jugpal S
authors.initials: JS
authors.lastname: Arneja
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000970:Antineoplastic Agents; D005938:Glucocorticoids